2012
DOI: 10.1016/j.jpedsurg.2011.12.024
|View full text |Cite
|
Sign up to set email alerts
|

Early alteration of urinary exosomal aquaporin 1 and transforming growth factor β1 after release of unilateral pelviureteral junction obstruction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 25 publications
0
10
0
Order By: Relevance
“…Currently available clinical tests are not adequate for predicting the course of urinary tract obstruction. Li et al [ 47 ] have reported that AQP1 in urinary EVs could be a possible candidate marker. They observed that urinary exosomal release of AQP1 was reduced in patients with unilateral pelviureteral junction obstruction who underwent pyeloplasty.…”
Section: Aquaporins In Urinary Extracellular Vesicles As Potentialmentioning
confidence: 99%
“…Currently available clinical tests are not adequate for predicting the course of urinary tract obstruction. Li et al [ 47 ] have reported that AQP1 in urinary EVs could be a possible candidate marker. They observed that urinary exosomal release of AQP1 was reduced in patients with unilateral pelviureteral junction obstruction who underwent pyeloplasty.…”
Section: Aquaporins In Urinary Extracellular Vesicles As Potentialmentioning
confidence: 99%
“…A PCN catheter should remain inserted for about 4-12 weeks [1], but patients with PCN drainage are at increased risk of further renal function loss and infection [4,11]. Transforming growth factor-β and urinary tubular enzymes have also been used to predict the recoverability of renal function after the relief from obstruction, though the efficacy and feasibility of these biological agents need further evaluation [14,15]. Renal biopsy may cause infection and bleeding, and given that the histopathological changes in the kidneys are often heterogeneous, the biopsy sample may not reflect the true extent of the effects of UPJO [11].…”
Section: Discussionmentioning
confidence: 99%
“…Differences in renal AQP expression levels in normal vs AKI tissue could help identify AKI in patients. AQPs 1, 2 expression is reduced in AKI rat models [36] and children with renal blockage injury show reduced expression of AQP1 [38] . Evidence suggests that AQP-uEV concentration in patient urine can be used as a biomarker to determine AKI severity; Sonoda et al have identified changes in AQP1 concentration in uEV in AKI rats with early AKI, without reduced urine osmolality or increased urine volume.…”
Section: Aqp-ev In the Urinary Systemmentioning
confidence: 92%
“…uEVs, exosomes, microparticles) depending on the focus of the study and findings; within the body of this review all are discussed as EV. System Aquaporin/s identified EV terminology Pathology/treatment Experimental model Authors Urinary 2 Low density exosomes Healthy Human [25] 2 Exosome-like Hepatic disease Mouse & rat [26] 1, 2 & 7 Exosomes Healthy Human [28] 1 & 2 Exosomes Healthy Human [29] 2 Exosomes Healthy Human [31] 1 & 2 Exosomes Healthy Human [32] 2 Exosomes Healthy Human [33] 2 Exosomes Desmopressin treatment Human cell line [35] 1 & 2 uEVs Acute Kidney Injury Rat [36] 1 Exosomes Acute Kidney Injury Rat [37] 1 Exosomes Pelviureteric junction obstruction Human [38] 1 & 2 Exosomes Transplant Human [39] 2 Exosomes Nephrosis Human [40] 2 ...…”
Section: Introductionmentioning
confidence: 99%